|
PRR24 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.826000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.627700E-02 |
| Normal-vs-Stage2 |
3.221600E-01 |
| Normal-vs-Stage3 |
3.997900E-02 |
| Normal-vs-Stage4 |
9.080000E-02 |
| Stage1-vs-Stage2 |
9.644200E-01 |
| Stage1-vs-Stage3 |
4.110400E-01 |
| Stage1-vs-Stage4 |
5.689800E-01 |
| Stage2-vs-Stage3 |
6.394800E-01 |
| Stage2-vs-Stage4 |
7.338400E-01 |
| Stage3-vs-Stage4 |
9.135000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.513900E-02 |
| Normal-vs-AfricanAmerican |
2.016200E-01 |
| Normal-vs-Asian |
2.036500E-02 |
| Caucasian-vs-AfricanAmerican |
9.873200E-01 |
| Caucasian-vs-Asian |
1.981200E-01 |
| AfricanAmerican-vs-Asian |
3.993000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.157590E-02 |
| Normal-vs-Female |
7.394000E-02 |
| Male-vs-Female |
2.404200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.783600E-02 |
| Normal-vs-Age(41-60Yrs) |
3.700000E-02 |
| Normal-vs-Age(61-80Yrs) |
3.350200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.986600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.163800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.271200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.493800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.103000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.915000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.282600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.573200E-01 |
| Classical-VS-Follicular |
5.154600E-01 |
| Classical-VS-Other |
9.848200E-01 |
| Classical-VS-Normal |
1.603500E-02 |
| Tall-VS-Follicular |
5.265800E-01 |
| Tall-VS-Other |
5.898600E-01 |
| Tall-VS-Normal |
8.512000E-01 |
| Follicular-VS-Other |
8.183600E-01 |
| Follicular-VS-Normal |
2.069000E-01 |
| Other-VS-Normal |
2.924000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.735900E-02 |
| Normal-vs-N1 |
6.339600E-03 |
| N0-vs-N1 |
9.694100E-02 |
|
|
